<DOC>
	<DOCNO>NCT00517114</DOCNO>
	<brief_summary>The purpose study evaluate efficacy rabeprazole ( pariet ) versus placebo treat reflux laryngitis Chinese patient . Patients attend voice clinic Department ENT , Queen Mary hospital suspect reflux laryngitis recruit . A questionnaire administer research assistant Department Medicine ENT , Queen Mary hospital . A 12-week course PPI versus placebo trial commence patient ' symptom sign document 6-week 12-week time . The study finish 12-week course rabeprazole .</brief_summary>
	<brief_title>Prospective Double-blinded Randomized Controlled Trial 12-weeks High Dose Rabeprazole ( Pariet ) Treatment Reflux Laryngitis Chinese Patients</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Laryngitis</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<criteria>Ambulatory patient age 1880 year old Patients newly present laryngitis . They 18 80 year age Has significant concomitant medical disease Pregnancy lactate woman Chronic cough attributable know chronic pulmonary tracheobronchial disease Previous glottal surgery , radiotherapy malignancy Acid suppressive therapy within 4 wk prior recruitment Pharyngolaryngeal infection previous 3 month Tracheal intubation previous 12 month Immunosuppression use inhale corticosteroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Reflux laryngitis</keyword>
</DOC>